Jeff Johnson's Stock Ratings

Baird Analyst

Jeff Johnson is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025

Overall Average Return

32.8%

Smart Score

77.5%

Overall Average Return Percentile

89th

Number of Ratings

1
Buy NowGet Alert
02/20/2025BBNXBuy Now
Beta Bionics
$11.1479.53%
Jeff Johnson77%
 → $20Initiates → NeutralGet Alert

Recent Analyst Stock Rating News

40-Year-Old Making $4K a Month in Dividends Reveals His Top 8 Stocks — 'We Don't Wear Fancy Clothes or Spend Money on Impressing Others'
Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
Don Bacon Supports $500B Medicaid Cuts Proposal Including Annual Eligibility Audits To Preserve 2017 Tax Cuts
Nebraska Representative Don Bacon (R-Neb.) has expressed his support for $500 billion in Medicaid cuts. This comes as congressional Republicans are striving to preserve the 2017 Tax Cuts and Jobs Act.
Travis Kelce Net Worth: How Much is the NFL Star Worth in April 2025?
NFL star Travis Kelce's net worth in April 2025 is $90 million, thanks to football, endorsements, a blockbuster podcast deal, and growing business ventures.
From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline
How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock
Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday
What 6 Analyst Ratings Have To Say About DexCom
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved